Stock

Unilever considers restocking supply for GSK's shopper staples – Bloomberg

©Reuters. FILE PHOTO: The Unilever company logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, United States, on February 17, 2017. REUTERS/Brendan McDermid/File Photo

(Reuters) – Unilever (NYSE:) Plc has held talks with banks about additional financing for a potentially sweetened offering for GlaxoSmithKline (NYSE:) Plc's consumer goods division, Bloomberg reported https://www.bloomberg.com/news/articles / 2022-01-16/unilever-allegedly-to-weigh-up-bid-for-glaxo-consumer-unit?sref=WJKVI5nK on Sunday, citing people familiar with the matter.

Unilever and GSK did not immediately respond to Reuters requests for comment.

The news came a day after GSK announced it had rejected a £50 billion ($68.37 billion) bid from Unilever for its consumer goods division. GSK said it received three bids from Unilever, the latest on December 20.

Unilever may eventually sell some non-core assets from GSK's portfolio to buyers, including private equity firms, which could help fund a takeover, the Bloomberg report added.

($1 = 0.7314 pounds)

Disclaimer: Fusion Media would like to remind you that the data contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are provided by market makers rather than exchanges and as such prices may not be accurate and may vary from actual market price meaning prices are indicative and not for trading purposes are suitable. Therefore, Fusion Media accepts no responsibility for any trading loss that you may incur as a result of using this data.

Fusion Media or anyone associated with Fusion Media shall not be liable for any loss or damage arising out of reliance on any information, including data, quotes, charts and buy/sell signals, contained on this website. Please educate yourself fully about the risks and costs associated with trading the financial markets as this is one of the riskiest forms of investment of all.

Related Articles